https://orcid.org/0000-0003-2334-5207
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pierre-Antoine Laurent, Daphne Morel, Lydia Meziani, Stephane Depil & Eric Deutsch. (2023) Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors. OncoImmunology 12:1.
Read now
Read now
Raj Satkunasivam, Kelvin Lim, Bin S Teh, Jonathan Guzman, Jun Zhang, Andrew Farach, Shu-Hsia Chen, Christopher JD Wallis, Eleni Efstathiou, Nestor F Esnaola & Guru P Sonpavde. (2022) A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial. Future Oncology 18:25, pages 2771-2781.
Read now
Read now
Articles from other publishers (18)
Jeremy P. Harris, Jino Park, Eric Ku, Steven Seyedin, Russell Stitzlein, Amanda Goldin, Wen-Pin Chen, Christine McLaren, Allen M. Chen & Warren Chow. (2024) A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma. Cancer Control 31.
Crossref
Crossref
Takeshi Sano, Ryoichi Saito, Rihito Aizawa, Tsubasa Watanabe, Kaoru Murakami, Yuki Kita, Kimihiko Masui, Takayuki Goto, Takashi Mizowaki & Takashi Kobayashi. (2023) Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma. International Journal of Clinical Oncology 28:12, pages 1573-1584.
Crossref
Crossref
Zelei Dai, Nian Li, Jun Wang, Chenfeng Tan, Yonggang Zhang & Lei Liu. (2023) Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov. Frontiers in Pharmacology 14.
Crossref
Crossref
Lahcene Belaidi, Pascal Wang, Kevin Quintin, Catherine Durdux, Etienne Giroux-Leprieur & Philippe Giraud. (2023) Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer. Cancers 15:21, pages 5127.
Crossref
Crossref
Yuji Tanaka, Tsukuru Amano, Akimasa Takahashi, Hiroki Nishimura, Hiroyuki Yamanaka, Yutaka Yoneoka, Shunichiro Tsuji & Takashi Murakami. (2023) Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report. Gynecologic Oncology Reports 49, pages 101265.
Crossref
Crossref
C. Aristei, O. Kaidar-Person, L. Boersma, M.C. Leonardi, B. Offersen, P. Franco, M. Arenas, C. Bourgier, R. Pfeffer, V. Kouloulias, Y. Bölükbaşı, I. Meattini, C. Coles, A. Montero Luis, V. Masiello, I. Palumbo, A.G. Morganti, E. Perrucci, V. Tombolini, M. Krengli, F. Marazzi, L. Trigo, S. Borghesi, A. Ciabattoni, I. Ratoša, V. Valentini & P. Poortmans. (2023) The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer. Critical Reviews in Oncology/Hematology 187, pages 104035.
Crossref
Crossref
Joris B. W. Elbers, Pascal A. Gunsch, Reno Debets, Stijn Keereweer, Esther van Meerten, Jaap Zindler, Yvette van Norden, Mischa S. Hoogeman, Gerda M. Verduijn, Michiel Kroesen & Remi A. Nout. (2023) HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial. BMC Cancer 23:1.
Crossref
Crossref
F. Cortiula, B. Reymen, S. Peters, P. Van Mol, E. Wauters, J. Vansteenkiste, D. De Ruysscher & L.E.L. Hendriks. (2022) Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches. Annals of Oncology 33:9, pages 893-908.
Crossref
Crossref
Willem J.A. Witlox, Bram L.T. Ramaekers, Benjamin Lacas, Cecile Le Pechoux, Alexander Sun, Si-Yu Wang, Chen Hu, Mary Redman, Vincent van der Noort, Ning Li, Matthias Guckenberger, Harm van Tinteren, Lizza E.L. Hendriks, Harry J.M. Groen, Manuela A. Joore & Dirk K.M. De Ruysscher. (2022) Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer. Radiotherapy and Oncology 170, pages 95-101.
Crossref
Crossref
Mengling Wu, Qianrui Huang, Yao Xie, Xuyi Wu, Hongbo Ma, Yiwen Zhang & Yong Xia. (2022) Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Giulia Petroni, Lewis C. Cantley, Laura Santambrogio, Silvia C. Formenti & Lorenzo Galluzzi. (2021) Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature Reviews Clinical Oncology 19:2, pages 114-131.
Crossref
Crossref
Giulia Cerrato, Juliette Humeau, Allan Sauvat, Oliver Kepp & Guido Kroemer. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
67
82
.
Lilia Bardoscia, Nadia Pasinetti, Luca Triggiani, Salvatore Cozzi & Angela Sardaro. (2021) Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation. Frontiers in Pharmacology 12.
Crossref
Crossref
Verdiana Trappetti, Jennifer M. Fazzari, Cristian Fernandez-Palomo, Maximilian Scheidegger, Vladislav Volarevic, Olga A. Martin & Valentin G. Djonov. (2021) Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma. International Journal of Molecular Sciences 22:14, pages 7755.
Crossref
Crossref
Lorenzo Galluzzi & Abhishek D. Garg. (2021) Immunology of Cell Death in Cancer Immunotherapy. Cells 10:5, pages 1208.
Crossref
Crossref
Stephanie T. H. Peeters, Evert J. Van Limbergen, Lizza E. L. Hendriks & Dirk De Ruysscher. (2021) Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?. Cancers 13:9, pages 2132.
Crossref
Crossref
Damiënne Marcus, Relinde I. Y. Lieverse, Carmen Klein, Amir Abdollahi, Philippe Lambin, Ludwig J. Dubois & Ala Yaromina. (2021) Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. Cancers 13:6, pages 1468.
Crossref
Crossref
Yona Keisari & Itzhak Kelson. (2021) The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules. Cells 10:2, pages 228.
Crossref
Crossref